Good afternoon. I call this meeting to order.
Welcome to meeting number 29 of the Standing Committee on Science and Research. The committee is meeting to study governance and accountability of federal science policy and institutions.
I would like to make a few comments for the benefit of the witnesses as well as the members.
Please wait until I recognize you by name before speaking. For those participating by video conference, click on the microphone icon to activate your mic and please mute yourself when you are not speaking. For those on Zoom, at the bottom of your screen, you can select the appropriate channel for interpretation: floor, English or French.
This is a reminder that all comments should be addressed through the chair.
I would like to welcome our witnesses for this panel.
We have Wyatt Tessari L'Allié, founder and executive director of AI Governance and Safety Canada. We are also have Dr. Stéphanie Michaud, president and chief executive officer of BioCanRx; and Robert Annan, president and chief executive officer of Genome Canada.
The witnesses will have five minutes for their opening remarks, and then we will go into our round of questioning with the members of Parliament.
Mr. Tessari L'Allié, we will start with you. Please go ahead.
